Search

Search Constraints

You searched for: Author/Creator Yamauchi, Masami

Search Results

1. A case of acute liver failure with echovirus infection diagnosed by a multi-virus real-time PCR system. (2021)

2. Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection—Pilot study. Issue 2 (29th November 2020)

3. Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab. Issue 42 (22nd October 2021)

4. Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab. Issue 42 (22nd October 2021)

5. Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib. (May 2020)

6. Construction of an anti-hepatitis B virus preS1 antibody and usefulness of preS1 measurement for chronic hepatitis B patients: Anti-HBV PreS1 antibody. Issue 3 (March 2022)

7. Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma. Issue 6 (6th January 2021)

8. Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAIL. (28th February 2022)

9. Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients. Issue 11 (7th September 2020)

10. Incidence of microsatellite instability‐high hepatocellular carcinoma among Japanese patients and response to pembrolizumab. Issue 7 (6th March 2020)